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The Ca2+-binding parvalbumin has been purified for the first time from rat kidney. Its biochemical and 
immunological properties were indistinguishable from the muscle counterpart. By immunohistochemical 
methods parvalbumin was localized in part of the distal tubule and proximal collecting duct, similar to the 
vitamin D-dependent Ca 2+-binding protein, calbindin-28K. Parvalbumin was found to be independent of 
the vitamin D status of the animal since its concentration remained unchanged in kidney extracts of normal, 
rachitic and vitamin D-replete rats. Both proteins may be involved in the regulation of intracellular Ca2+ 
in kidney. 
Ca2+ binding protein Parvalbumin 
1. INTRODUCTION 
The Ca2+-binding parvalbumin (PV) has been 
found in muscle and non-muscle tissues of the rat 
[1,2], including some major target organs for the 
hormonally active vitamin D metabolite, 
la,25-dihydroxycholecalciferol (lcu,25-(OH)zDs). 
Vitamin D is known to enhance the Ca2+ transport 
across these tissues and concomitantly induces the 
formation of the vitamin D-dependent calcium- 
binding proteins, calbindin-10u and -28~ [3-51 
which are possibly involved in Ca’+-transport/buf- 
fering functions also proposed for PV. It has been 
noticed that PV and calbindin-28K coexist in the 
ameloblast of teeth, calcified cartilage of bone and 
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in some neurons (e.g. Purkinje cells) of the 
cerebellum [ 1,2,6]. 
Here, we isolated for the first time PV from rat 
kidney, determined its biochemical properties, 
compared them with the muscle counterpart and 
determined its concentration and localization in 
kidneys of normal and rachitic animals to test if 
also the biosynthesis of PV (similar to those of 
calbindins) may depend on the vitamin D status of 
the animal. 
2. MATERIALS AND METHODS 
2.1. Proteins 
PV from rat skeletal muscle [7], calmodulin 
from calf brain [8] and calbindin-10/28K [9] were 
isolated as described. 
2.2. Antibodies 
Antisera against rat muscle PV were raised in 
rabbits [1,2]. The antibody was purified from 
whole serum by ammonium sulfate fractionation 
and chromatography on a PV affinity column. 
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2.3. Animals 
Vitamin D-deficient, vitamin D-supplemented 
and control animals were obtained from 
Hoffmann-La Roche [lO,l 11. The vitamin D defi- 
ciency was examined by: (i) X-ray analysis of the 
epiphyseal growth plates of the hindlimbs; (ii) 
determination of the plasma concentration of 
la,25-(OH)zDs; (iii) and disappearance of 
calbindin-10x from rat intestine. 
2.4. Purification of kidney PV 
Kidneys from 3-6-month-old rats (SIV-50) were 
pooled and frozen immediately after being killed. 
Extraction was carried out at 4°C in 2 vols of 
4 mM EDTA, pH 7.5, containing various protease 
inhibitors [8]. After homogenization (Virtis 
blender 4 x 15 s, full speed), and centrifugation 
(100000 x g) the supernatant was directly applied 
to an immune-affinity column (10 x 0.6 cm) 
prepared by coupling of anti-PV IgG to CNBr- 
activated Sepharose 4B (Pharmacia). After 
washing with phosphate-buffered saline (PBS, 
containing 137 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na2HP04, 1 mM MgClz, 0.1 mM CaC12, pH 7.3), 
followed by PBS containing in addition 1 mM 
EDTA and 1 M NaCl, PV was finally eluted with 
3 M KI, 0.1 M Tris-HCl, pH 8. The protein was 
immediately dialyzed against Hz0 (48 h) and 
lyophilized. 
2.5. HPLC 
Proteins were separated [1,7] on an Aquapore 
RP-300 column (4.6 x 30 mm, RP-8, 10 pm parti- 
cle size, 300 A pore size support) at a flow rate of 
2 ml/min. Buffer systems: IA, 50 mM Tris-HCl, 
pH 7.5, 0.1 mM CaC12 (or 0.1 mM EGTA); IB; 
same as in A except 60% (v/v) acetonitrile. 
2.6. 20 PAGE 
i4C-labeled proteins were analyzed as described 
1781. 
2.7. Immunoblotting 
Proteins were first separated on ID-PAGE 
(15%) and then transferred onto nitrocellulose 
(Millipore) using an LKB apparatus with a con- 
stant voltage of 15 V for 16 h [ 121. Antiserum 
against rat muscle PV (raised in rabbits) and 
peroxidase-coupled goat anti-rabbit IgG (Miles) 
were diluted 1: 1000 and 1: 1500, respectively. The 
52 
affinity-purified antibodies were used in a concen- 
tration of 1 ,ug/ml. Final staining was carried out 
with chloronaphthol as a substrate. 
2.8. Immunohistochemistry 
F&Albino rats were anesthetized with sodium 
pentobarbital, perfused through the aorta with 
500 ml of Bouin fluid, the tissue dissected out, 
dehydrated in graded ethanol and finally embed- 
ded in paraffin. The immunostaining was per- 
formed using the PAP method [1,2]. Antiserum 
against rat PV was diluted 1: 1000 to 1:20000 in 
PBS and the affinity-purified antibodies in a dilu- 
tion of 0.2 to 1 rg/ml, goat anti-rabbit IgG 1: 5 
(Nordic) and the PAP complex 1:200 
(Sternberger-Meyer). Control incubations used 
preimmune sera or preabsorbed antisera. 
2.9. RIA 
PV was iodinated [13]. In short, 100 pl of the 
1251-labeled PV (3000 cpm) were mixed with 100 /cl 
kidney extract (before and after heat treatment) 
and varying amounts of unlabeled antigen. After 
3 h incubation at 37”C, polyethyleneglycol and y- 
globulin were added and the solution centrifuged. 
Pellets were counted in an LKB y-counter. 
2.10. Double-antibody solid-phase enzyme 
immunoassay 
Briefly, anti-PV IgG was coated onto the surface 
of microtiter wells (1 pg/well, micro ELISA plate, 
Dynatech) and further processed [14]. 
3. RESULTS 
3.1. Isolation of PV from kidney 
Conventional as well as HPLC techniques ap- 
plied for the isolation of PV from muscle and 
brain [ 1,7] were unsuccessful. First, because of the 
high proteolytic activity in kidney extracts and 
second because even after ‘final’ purification, the 
protein fractions were still contaminated with 3-5 
low-molecular-mass proteins (mainly cyto- 
chromes), some of them eluting with identical 
hydrophobicities to PV. Therefore kidney PV was 
purified on an immune-affinity column. Heat- 
treated extracts (30 min, 8S°C) were directly 
applied onto an anti-PV IgG-Sepharose column. 
After several washing steps, homogeneous PV was 
eluted with 3 M KI, 0.1 M Tris-HCl buffer, pH 8. 
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Approx. 1 mg of protein was obtained from 1 kg 
tissue. 
3.2. Characterization of kidney PV 
3.2.1. 2D-PAGE 
The EDTA extracts of rat kidney (after heat 
treatment) still contained approx. 30 distinct pro- 
teins with kidney PV clearly recognizable by its M, 
of 12000 and p1 of 4.9 (fig.la). After purification 
on the immune-affinity column, PV was obtained 
in a homogeneous form (fig. 1 b) co-migrating with 
muscie parvalbumin (MI 12OOO/pI 4.9, fig.Ic). 
3.2.2. HPLC analysis 
Purified kidney PV when chromatographed in 
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Fig. 1. ZD-PAGE (15%) of (a) heat-treated extract from 
rat kidney (1SOpg protein), (b) purified kidney PV 
(5 pg) and (c) comigration of kidney and muscle PVs 
(5 pg each). Proteins were L4C-labeied by reductive 
methylation and visualized by fluoro~aphy. PV was 
identified by its Mr = 12000, pZ = 4.9. Arrows show 
position of PV; arrowheads position of cytochromes c, 
the presence of 1 mM CaClz was eluted in a single 
peak at 44% acetonitrile (fig.2a, left) at the same 
position as muscle PV (fig.2b, left) but distinct 
from calmodulin (fig.2c, left). Kidney and muscle 
PVs were considerably shifted in their hydro- 
phobicity when chromatographed in the presence 
TRIS - Cat32 TRIS - EGTA 
0 
.30% 
rPV 
@ 
/ 
I PV 
___/- 
ptC&l 
u 
Fig.2. HPLC of (a) purified kidney PV (S&g protein), 
(b) muscle PV (lopg), (c) CaM @c/g). Left, in the 
presence of 1 mM CaC%; right, with i mM EGTA. (d) 
Blanks. The gradient was O-1OWo buffer B in 15 min. 
Only part of the chromatogram ranging from 30-70% 
buffer B is shown. 
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of EGTA and eiuted at 64% acetonitrile. How- 
ever, in the Ca2+-free buffer system the kidney PV 
sometimes showed three closely spaced peaks 
(fig.Za, right). When analyzed on ZD-PAGE, only 
the peak eluting at the same position as muscle PV 
showed a protein spot (M 1200O/pZ 4.9). The 
other two peaks did not show any protein bands 
and most probably represent degradation products 
of kidney PV. 
3.2.3. Peptide maps 
Purified kidney PV was digested with TPCK- 
treated trypsin and peptides analyzed by HPLC. 
The peptide pattern of the kidney and muscle pro- 
teins were indistinguishable but different to those 
of calmodulin (not shown). 
3.2.4. Immunoblotting 
Kidney and muscle PVs (fig.3) were first 
separated on lD-PAGE and then transferred onto 
a nitrocellulose sheet. The immunoreaction of 
b c el 
Fig.3. Fluorograms of lD-PAGE (l#o) of (a) kidney 
PV (1 fig) and (b) muscle PV (1 pg) and corresponding 
immunoblots (c,d). 
anti-muscle PV serum with kidney and muscle PV 
demonstrated immunological identity (fig.3c,d). A 
parallel gel (fig.3a,b) was run with identical 
samples after t4C labeling of the proteins by reduc- 
tive methylation, and visualized by fluorography. 
3.3. PV in normal and rachitic rats 
Immunoreacti~ty in rat kidney (fig.4a) was 
found in a portion of the tubular system, iden- 
tifiable as part of the distal tubule and proximal 
collecting duct. The immunoreactivity was 
homogeneously distributed in the cytoplasm of 
these cells and also seemed to occur in the nuclei. 
No staining has been found in the kidney in con- 
trols, incubated with pre-immune- or pre-adsorbed 
antisera (fig4b). Kidney extracts (after heat treat- 
ment) of normal, rachitic and vitamin D- 
supplemented (not shown) animals were analyzed 
for PV on 2D-PAGE. The intensity of the PV 
spot, recognized by its Mr of 12000 and pi of 4.9, 
remained unchanged in all extracts indicating an 
independence of PV from lcu,25-(OH)zDr (not 
shown). Quantitative analysis of PV in these ex- 
tracts was performed by RIA and a double- 
antibody immunoassay. PV concentrations 
(1 mg/kg tissue wet wt) remained unchanged when 
extracts (before and after heat treatment) of nor- 
mal, rachitic and vitamin D-replete animals were 
analyzed confirming an independence of PV from 
la,25(OH)zDj as found above. 
4. DISCUSSION 
Besides muscle, trace amounts of PV- 
immunoreactive material have also been found in 
several non-muscle tissues of various species but 
isolation, characterization and anatomical local- 
ization have so far only been carried out in the cen- 
tral nervous system [1,2]. Previously we reported 
[15] that also rat kidney extracts contained a pro- 
tein with an isoelectric point (pZ 4.9) identical to 
PV but with a slightly lower molecular mass. This 
protein cross-reacted with serum directed against 
rat muscle PV, It was suggested 1151 that this pro- 
tein may either represent another as yet unknown 
kidney protein or may be a proteolytic fragment of 
PV, since kidney extracts are known to contain 
high proteolytic activities. By application of 
immune-affinity chromatography, a genuine PV 
could be isolated in small quantities of fresh and 
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Fig.4. Immunohistochemical localization of PV in rat kidney. (a) Section through the kidney cortex of a normal adult 
rat incubated with PV antiserum. A portion of the tubular system, namely part of the distal tubule and proximal 
collecting duct was stained. (b) Control incubated with pre-immune s rum. D, distal tubule; S, proximal collecting duct; 
G, glomerulus. 
quickly frozen material. The lower molecular mass 
observed earlier probably resulted from limited 
proteolysis. This view is supported by the fact that 
PV in kidney extracts was degraded upon storage 
(even in the presence of various protease in- 
hibitors). A direct comparison of the kidney PV 
with its muscle (or brain) counterpart revealed 
identities in molecular masses, isoelectric points, 
retention times on reverse-phase supports (in the 
presence and absence of Ca2+) as well as in their 
immunological properties. The following reasons 
prompted us also to investigate a possible 
dependency of the biosynthesis of PV from 
vitamin D: (i) structurally homologous vitamin D- 
dependent, calbindin-10x and -28K, have been 
found in kidneys of chicken, several mammalian 
species including man [3-5,16-201. These previous 
studies, however, produced some conflicting 
results on their vitamin D-dependence and the 
regulatory effect of their cellular expression; (ii) 
PV and calbindin-28x co-exist in some neurons and 
ameloblasts of teeth [1,2]; (iii) PV and 
calbindin-28K are thought to regulate intracellular 
translocation of Ca” or represent intracellular 
Ca2+ pools. Although PV is found in some vitamin 
D target tissues and is co-localized with 
calbindin-28k, its synthesis in kidney as found in 
the cerebellum [1 l] seems to be independent from 
the vitamin D status of the animal. 
PV immunoreactivity was found in a portion of 
the tubular system of the kidney cortex of a normal 
adult rat, identifiable as a part of the distal tubule 
and proximal collecting duct. A similar distribu- 
tion has been described for calbindin-28x. In the 
kidney of chicken, calbindin-28x immunoreactivity 
was found in the distal convoluted tubule, the in- 
itial collecting tubule and early parts of the col- 
lecting tubule and similar localization have been 
found in other species [3-5,16-201. Calbindin-10x 
has also been found in mouse kidney [16,17] and 
immunoreactivity has been observed, e.g. in the rat 
nephron, with strongest reaction in cells of the 
distal convoluted tubules but also in the macula 
densa and collecting duct. Therefore kidney con- 
tains either calbindin28k as reported in rat [ 181 or 
even two calbindin-28x and -10~ as found in mouse 
[16,17,19] whose synthesis seems to be dependent 
on la,25(OH)zDs, but in addition, rat kidney also 
contains the Ca 2+-binding PV whose concentration 
seems unaffected by the vitamin D status. 
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